Tirzepatide Ireland: Research Overview & Lab-Grade Supply

Tirzepatide Ireland: this page is a plain-English research overview of tirzepatide for Irish laboratories, universities and research teams. It explains what the molecule is, what published laboratory studies have looked at, and what documentation comes with every batch of our research-grade tirzepatide.

Tirzepatide supplied by Peptides Lab Ireland is for laboratory research use only. It is not a medicine, it is not the same as licensed products such as Mounjaro, and it must not be used in humans or animals.

What Is Tirzepatide?

Tirzepatide is a synthetic dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 (glucagon-like peptide-1) receptor. It is a 39-amino acid peptide based on the native GIP sequence, modified to also bind GLP-1R with high affinity. Its molecular formula is C₂₂₅H₃₄₈N₄₈O₆₈, with a molecular weight of approximately 4,813.5 Da. A C20 fatty diacid chain conjugated via a linker to lysine at position 20 extends its half-life to approximately five days.

This dual receptor activity distinguishes tirzepatide mechanistically from pure GLP-1 agonists such as semaglutide, and has generated substantial research interest in the comparative signalling profiles of GIP and GLP-1 pathways.

Tirzepatide in Research Contexts

Dual Incretin Signalling Research

The primary focus of tirzepatide-related laboratory research is its dual incretin mechanism. Research has examined how simultaneous activation of both GIPR and GLP-1R modifies insulin secretion dynamics, glucagon suppression, beta-cell function, and energy expenditure compared to single-receptor agonism. This comparative mechanistic research is active across European endocrinology departments.

Adipose Tissue and Energy Metabolism

Laboratory studies have looked at how dual GIP and GLP-1 receptor signalling affects fat cells, including lipolysis, adipokine secretion and brown adipose tissue activity, in cell and animal models.

Hepatic Metabolism and MASH Research

Research teams also use tirzepatide in preclinical liver models to study hepatic lipid accumulation, inflammation and fibrosis pathways.

GIP Receptor Biology

Tirzepatide’s use in research has helped drive renewed interest in GIP receptor biology itself a field that was historically understudied relative to GLP-1. Studies examining GIPR expression patterns, its role in fat tissue, and its interaction with GLP-1R signalling have increased substantially since tirzepatide’s clinical emergence.

Tirzepatide Research Overview: What the Published Studies Say

In simple terms, tirzepatide is one molecule that switches on two hormone receptors (GIP and GLP-1) instead of one. Most of the lab research on it tries to answer one question: what changes when both receptors are activated together?

• Discovery and design. Eli Lilly scientists described how the molecule (then called LY3298176) was built on the GIP sequence and tuned to also activate the GLP-1 receptor, and reported its receptor activity in cell and animal studies (Coskun et al., Mol Metab 2018; PMID 30473097).
• How it signals. Follow-up cell work found tirzepatide is “imbalanced”: it acts more like native GIP at the GIP receptor, but signals differently at the GLP-1 receptor, favouring cAMP signalling over beta-arrestin recruitment (Willard et al., JCI Insight 2020; PMID 32730231).

These two papers are a good starting point for any team planning receptor-signalling or comparative incretin work. For a side-by-side look at related compounds, see our GLP-1, tirzepatide and retatrutide comparison, the retatrutide vs tirzepatide guide and our semaglutide Ireland overview.

Quality Standards for Tirzepatide Research Supply in Ireland

Peptides Lab Ireland supplies research-grade tirzepatide with the following on every batch:

• HPLC Purity Certificate , batch-specific, ≥98% purity
• Mass Spectrometry Identity Report
• Batch-specific Certificate of Analysis (CoA)
• Lyophilised format for stability

Dispatched from Ireland with cold-chain packaging and tracked delivery across all Irish addresses. View batch details on the tirzepatide product page, read our guide to reading a CoA, or email research@peptideslabireland.com.

Frequently Asked Questions

Is research-grade tirzepatide the same as Mounjaro?

No. Mounjaro and Zepbound are licensed pharmaceutical products manufactured under GMP conditions for human therapeutic use. Research-grade tirzepatide is manufactured to research purity standards for laboratory study only. It isn’t a pharmaceutical product and must not be used for human administration.

Is tirzepatide legal to buy in Ireland for research?

Research-grade tirzepatide isn’t a scheduled controlled substance under Irish law and can be legally purchased for in-vitro laboratory research by qualified researchers. See: Are Peptides Legal in Ireland?

How does tirzepatide differ from semaglutide in research applications?

Semaglutide is a pure GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 receptor agonist. In research settings, tirzepatide is used to study the combined signalling profile of both incretin receptors, enabling comparative mechanistic work that isn’t possible with GLP-1 agonists alone.

Does Peptides Lab Ireland ship tirzepatide across Ireland?

Yes , tracked, cold-packaged delivery to all Republic of Ireland addresses. Standard delivery 1–3 working days from dispatch.

Research-grade tirzepatide is supplied by Peptides Lab Ireland for in-vitro laboratory and scientific research purposes only. It isn’t a licensed medicine. It must not be administered to humans or animals. Peptides Lab Ireland operates in compliance with HPRA guidelines. For medical concerns, consult a qualified healthcare professional.